Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 4, 2015, Pages

  Ewald, Hannah ^a   Raatz, Heike ^a   Boscacci, Remy ^b   Furrer, Hansjakob ^b   Bucher, Heiner C ^a   Briel, Matthias ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE; TRIMETHOPRIM;

AMBIENT AIR; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; DATA BASE; DEATH; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOXEMIA; LUNG ALVEOLUS OXYGEN TENSION; MORTALITY RATE; PATIENT CARE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANOXIA; META ANALYSIS; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS;

ADRENAL CORTEX HORMONES; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANOXIA; CHEMOTHERAPY, ADJUVANT; HUMANS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL;

EID: 84941782439     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006150.pub2     Document Type: Review

References (42)

1. Bozzette SA, Sattler FR, Chiu J, Wu AW, Gluckstein D, Kemper C, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. New England Journal of Medicine 1990;323:1451-7.
2. Clement M, Edison R, Turner J, Montgomery B, Luce J, Feigal D, et al. Corticosteroids as adjunctive therapy in severe Pneumocystis carinii pneumonia: a prospective placebo-controlled trial. American Review of Respiratory Disease 1989;139:A250 (abstract).
3. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. New England Journal of Medicine 1990;323:1444-50.
4. Montaner JS, Lawson LM, Levitt N, Belzberg A, Schechter MT, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine 1990;113:14-20.
5. Nielsen TL, Eeftinck Schattenkerk JK, Jensen BN, Lundgren JD, Gerstoft J, van Steenwijk RP, et al. Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study. Journal of Acquired Immune Deficiency Syndromes 1992;5:726-31.
6. Terblanche AJ, Green RJ, Rheeder P, Wittenberg DF. Adjunctive corticosteroid treatment of clinical Pneumocystis jiroveci pneumonia in infants less than 18 months of age - a randomized controlled trial. South African Medical Journal 2008;98:287-90.
7. Walmsley S, Levinton C, Brunton J, Muradali D, Rappaport D, Bast M, et al. A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995;8:348-57.
8. Jeantils V, Nguyen G, Bacle F, Thomas M. Adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in AIDS. Therapie 1993;48:70-1.
9. Montaner JS, Guillemi S, Quieffin J, Lawson L, Le T, O'Shaughnessy M, et al. Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS). Tubercle and Lung Disease 1993;74:173-9.
10. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR. Recommendations and Reports 2004;53(RR-15):1-112.
11. Bye MR, Cairns-Bazarian AM, Ewig JM. Markedly reduced mortality associated with corticosteroid therapy of Pneumocystis carinii pneumonia in children with acquired immunodeficiency syndrome. Archives of Pediatrics and Adolescent Medicine 1994;148(6):638-41.
12. Panel on Opportunistic Infections in HIV-Infected Adults, Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://www.aidsinfo.nih.gov/contentfiles/adult_oi.pdf 2013.
13. No authors listed. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. New England Journal of Medicine 1990;323:1500-4.
14. Delclaux C, Zahar J, Amraoui G, Leleu G, Lebargy F, Brochard L, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carnii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. Clinical Infectious Diseases 1999;29:670-2.
15. European AIDS Clinical Society. Guidelines. Version 7.0. http://www.eacsociety.org/Guidelines.aspx 2013.
16. Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clinical Infectious Diseases 2003;36:70-8.
17. Frieden TR, Popovic T, Stephens JW, Solomon SL, Bernhardt JM, Daniel KL, Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 2009; Vol. 58, issue RR-11:1-166.
18. Gallant JE, Chaisson RE, Moore RD. The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest 1998;114:1258-63.
19. Grant AD, Djomand G, Smets P, Kadio A, Coulibaly M, Kakou A, et al. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'Ivoire. AIDS 1997;11(11):1357-64.
20. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.) 2008;336(7650):924-6. [PUBMED: 18436948]
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
23. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
24. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 2000;30 Suppl 1:S5-14.
25. Lambertus MW, Goetz MB, Murthy AR, Mathisen GE. Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Chest 1990;98:38-43.
26. Marx A, Bucher HC. Numbers needed to treat derived from meta-analysis: a word of caution. ACP Journal Club 2003;138:A11-2.
27. McLaughlin GE, Virdee SS, Schleien CL, Holzman BH, Scott GB. Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure. Journal of Pediatrics 1995;126(5 Pt 1):821-4.
28. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-9.
29. Moon SM, Kim T, Sung H, Kim M, Kim S, Choi S, et al. Outcomes of moderate-to-severe pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients. Antimicrobial Agents and Chemotherapy 2011;55(10):4613-8.
30. Nelson MR, Erskine D, Hawkins DA, Gazzard BG. Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 1993;7:375-8.
31. Panel on Opportunistic Infections in HIV-Exposed, HIV-Infected Children. Silberry GK, Abzug MJ, Nachmann S, Brady MT, Dominguez KL, Handelsmann E, et al. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Department of Health and Human Services; http://aidsinfo.nih.gov/guidelines 2013.
32. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998;113:1215-24.
33. Randall CJ, Yarnold PR, Schwartz DN, Weinstein RA, Bennett CL. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. American Journal of Respiratory and Critical Care Medicine 2000;162:393-8.
34. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
35. Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carnii pneumonia in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1988;109:280-7.
36. Sax PE. Treatment of Pneumocystis infection in HIV-infected patients. http://www.uptodate.com/contents/treatment-of-pneumocystis-infection-in-hiv-infected-patients?source=see_link (accessed 16 February 2015) 2012.
37. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clinical Infectious Diseases 2002;34:1098-107.
38. Sistek CJ, Wordell CJ, Hauptman SP. Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients. Annals of Pharmacotherapy 1992;26:1127-33.
39. Sleasman JW, Hemenway C, Klein AS, Barrett DJ. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. American Journal of Diseases of Children 1993;147(1):30-4.
40. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323:101-5.
41. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerging Infectious Diseases 2002;8:891-6.
42. Briel M, Bucher H, Boscacci R, Furrer H. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006150]